Search Within

Amin Taher Yaqubie

Formats
  1. Meeting Abstract (12)
  2. Journal Article (11)
Groups
  1. Department of Medicine (23)
  2. Solid Tumor Oncology Division (23)
  3. Gastrointestinal Oncology Service (22)
  4. Center for Pancreatic Cancer Research (12)
  5. Epidemiology and Biostatistics (12)
  6. GSK Faculty (11)

More Groups

People
  1. Ghassan Abou-Alfa (19)
  2. James Harding (13)
  3. Imane El Dika (10)
  4. Eileen O'Reilly (9)
  5. David Solit (7)
  6. Jinru Shia (7)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2023 (5)
  4. 2022 (4)
  5. 2021 (5)
  6. 2015 (1)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Annals of Oncology (2)
  3. Cancer Medicine (2)
  4. The Oncologist (2)
  5. Cancer Research Communications (1)
  6. JCO Global Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (12)
  2. Oxford University Press (4)
  3. Wiley Blackwell (2)
  4. American Association for Cancer Research (1)
  5. Karger (1)
  6. Springer (1)

More Publishers

Results (23)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neratinib alone or in combination with immune checkpoint inhibitors with or without mammalian target of rapamycin inhibitors in patients with fibrolamellar carcinoma
    Journal Article

    Abou-Alfa, G. K.; Meyer, T.; Do, R. K. G.; Piha-Paul, S. A.; Light, J. S.; Sherrin, S.; Yaqubie, A.; O'Neill, A. C.; Harding, J. J.; Al-Rajabi, R.; more...
    Liver Cancer (2025)

    Fulltext@MSK | Save
  • Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapy
    Journal Article

    Cowzer, D.; Chou, J. F.; Walch, H.; Keane, F.; Khalil, D.; Shia, J.; Do, R. K. G.; Yarmohammadi, H.; Erinjeri, J. P.; El Dika, I.; more...
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Clinical and genomic characterization of ERBB2-altered gallbladder cancer: Exploring differences between an American and a Chilean cohort
    Journal Article

    Mondaca, S.; Walch, H.; Sepúlveda, S.; Schultz, N.; Muñoz, G.; Yaqubie, A.; Macanas, P.; Pareja, C.; Garcia, P.; Chatila, W.; more...
    JCO Global Oncology (2024)

    Fulltext@MSK | Save
  • Fibrolamellar carcinoma registry: Opportunities and challenges
    Meeting Abstract

    Al Mahmasani, L.; Capanu, M.; Losert, K.; Lowery, M. A.; Hennessy, M.; Ray, M.; Chambers, S.; Yaqubie, A.; Zarski, A.; El Dika, I. H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Body mass index (BMI) as a prelude to hepatocellular carcinoma (HCC) and metabolic dysfunction-associated steatohepatitis (MASH) risk factors in patients with no identified risk factor for developing hepatocellular carcinoma (HCC)
    Meeting Abstract

    Al Mahmasani, L.; Capanu, M.; Srivastava, A.; Chou, J. F.; Shia, J.; El Dika, I. H.; Yaqubie, A.; Harding, J. J.; O'Reilly, E. M.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • CALGB 80802 (Alliance): Impact of sorafenib with and without doxorubicin on hepatitis C infection in patients with advanced hepatocellular carcinoma
    Journal Article

    Abou-Alfa, G. K.; Geyer, S. M.; Nixon, A. B.; Innocenti, F.; Shi, Q.; Kumthekar, P.; Jacobson, S.; El Dika, I.; Yaqubie, A.; Lopez, J.; more...
    Cancer Research Communications (2024)

    Fulltext@MSK | Save
  • Targeted molecular profiling of circulating cell-free DNA in patients with advanced hepatocellular carcinoma
    Journal Article

    Cowzer, D.; White, J. B.; Chou, J. F.; Chen, P. J.; Kim, T. H.; Khalil, D. N.; El Dika, I. H.; Columna, K.; Yaqubie, A.; Light, J. S.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Outcomes in advanced hepatocellular carcinoma (HCC) patients (pts) treated with immune checkpoint inhibitors (ICI)
    Meeting Abstract

    Cowzer, D.; Capanu, M.; Keane, F.; Khalil, D.; Shia, J.; Do, R.; Chou, J.; Walch, H.; El Dika, I.; Yaqubie, A.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Patients (pts) with advanced hepatocellular carcinoma (HCC) with long-term response to immune checkpoint inhibitor (ICI) therapy
    Meeting Abstract

    Keane, F.; Cowzer, D.; Khalil, D.; Shia, J.; Do, R.; Folorunso, S.; El Dika, I.; Yaqubie, A.; Kim, T.; O'Reilly, E.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Fertility post immune checkpoint blockade
    Meeting Abstract

    Ogle, M.; Harrold, E.; O'Brien, E.; Weiss, J. A.; Yaqubie, A.; Sinopoli, J. C.; Postow, M. A.; Cercek, A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save